glp-1 cardiovascular outcomes 2025 news Association of inhibitors with in patients undergoing coronary artery bypass surgery Stopping GLP-1 drugs can quickly – Heart benefits are erased if

Too stiff a scaffold can impair remodeling

Patients with higher body mass may have larger volumes of distribution, which could theoretically prolong elimination time, though this effect is generally modest compared to other factors

Currently licensed standard-dose diabetes tablets in the UK generally yield lower average weight loss results than dedicated weight loss injections

This effect is diminished by the withdrawal stage, which facilitates release of corticotropin-releasing factor and dynorphin, activating the stress system, including hubs like the amygdala [5]

Many individual participants exceeded these averages substantially, while others fell below them

Plasma GLP-1 is increased and this is responsible in part for weight loss and metabolic improvement which occurs before weight loss (55) 2